Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Clinical Research (Excluding Clinical Trials)

Abstract 3382: Exosomes analysis in non-small cell lung cancer: looking for a clinical application

Christian D. Rolfo, Marta Castiglia, Marco Giallombardo, Jorge Chacartegui, Nele Van Der Steen, Inge Mertens, Marc Peeters, Antonio Russo and Patrick Pauwels
Christian D. Rolfo
Antwerp University Hospital - Phase I - Early Clinical Trials Unit, Oncology, Edegem, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Castiglia
Antwerp University Hospital - Phase I - Early Clinical Trials Unit, Oncology, Edegem, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Giallombardo
Antwerp University Hospital - Phase I - Early Clinical Trials Unit, Oncology, Edegem, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Chacartegui
Antwerp University Hospital - Phase I - Early Clinical Trials Unit, Oncology, Edegem, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nele Van Der Steen
Antwerp University - Center for Oncological Research (CORE) Antwerp, Laboratory of Cancer Research and Clinical Oncology, Wilrijk, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge Mertens
Flemish Institute for Technological Research (VITO), Mol, Belgium & CFP-CeProMa, University of Antwerp, Wilrijk, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Peeters
Antwerp University Hospital - Oncology Department, Edegem, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Russo
University of Palermo, Department of Surgical, Oncology and Oral Sciences – Medical Oncology, Palermo, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Pauwels
Antwerp University Hospital - Molecular Pathology Unit, Pathology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Edegem, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2015-3382 Published August 2015
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA

Abstract

BACKGROUND

Cancer cells produce a heterogeneous mixture of vesicular, organelle-like structures (microvesicles or MVs) into their surroundings including blood and body fluid. In particular exosomes are biological nanovescicles (40-100 nm) that are formed by the inward budding of multivescicular bodies (MVB), as a component of the endocytic pathway. They are released from different cell types under both normal and pathological conditions. Exosomal content is composed by proteins, DNA, mRNA and microRNA (miRNA) that are transferred to distant site and mediate inter-cellular communication.

PURPOSE OF THE STUDY

The aim of this pilot study is to investigate whether exosomes isolation from clinical samples (plasma from NSCLC patients) is feasible. Furthermore we have analyzed a panel of 7 miRNA related to NSCLC.

EXPERIMENTAL DESIGN AND METHODS

The study population was selected among lung cancer patients diagnosed with NSCLC, histotype adenocarcinoma, in the Oncology department of Antwerp University Hospital. A total of 12 patients participated in the project. Six blood samples from healthy volunteers were also collected. After obtaining the informed consent, blood samples (10 ml) were stored in the UZA-tumor biobank. Clinical data were also collected from patients’ medical records.

Exosomes were isolated by means of both Density Gradient (DG) centrifugation and the Total Exosome Isolation kit (from plasma) (Invitrogen) according to manufacturers’ instructions. The Total exosome RNA and protein isolation kit (Invitrogen) was used for proteins recovery from exosome. Extracted proteins are used for western blot analysis aimed at the identification of specific exosome protein markers: CD63, ALIX and TSG101. Nanoparticle Tracking Analysis (NTA) was performed by means of the NanoSight NS500 instrument. In order to visualize the isolated exosomes a TEM (Transmission Electron Microscopy) analysis was performed.

The total exosome RNA and protein isolation kit (Invitrogen) was used to extract small-RNA from exosomal samples. The analysis of 7 miRNAs (miR-30b, -30c, -103, -122, -195, -221, -222) was performed on the LightCycler 480 (Roche) and the fold change was calculated according to the formula 2ααCq. miR-1228 was used has endogenous control to normalize the reaction.

RESULTS

• ALIX protein is a reliable protein marker for exosome identification

• TEM analysis have shown that exosomes can be isolated in NSCLC plasma samples

• 7 selected miRNAs are strongly deregulated in our clinical samples and seem related to staging

• miR30b and -30c might be related to squamous cell carcinoma histotype

CONCLUSION

The analysis of exosomes in NSCLC could represent a noninvasive test for patients’ management. With this pilot study we have demonstrated that exosome analysis and exosomal miRNA profiling is feasible. Due to the small sample size we cannot make significant statistic conclusion. Further analyses in a larger series are needed.

Citation Format: Christian D. Rolfo, Marta Castiglia, Marco Giallombardo, Jorge Chacartegui, Nele Van Der Steen, Inge Mertens, Marc Peeters, Antonio Russo, Patrick Pauwels. Exosomes analysis in non-small cell lung cancer: looking for a clinical application. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3382. doi:10.1158/1538-7445.AM2015-3382

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 75 (15 Supplement)
August 2015
Volume 75, Issue 15 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 3382: Exosomes analysis in non-small cell lung cancer: looking for a clinical application
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 3382: Exosomes analysis in non-small cell lung cancer: looking for a clinical application
Christian D. Rolfo, Marta Castiglia, Marco Giallombardo, Jorge Chacartegui, Nele Van Der Steen, Inge Mertens, Marc Peeters, Antonio Russo and Patrick Pauwels
Cancer Res August 1 2015 (75) (15 Supplement) 3382; DOI: 10.1158/1538-7445.AM2015-3382

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 3382: Exosomes analysis in non-small cell lung cancer: looking for a clinical application
Christian D. Rolfo, Marta Castiglia, Marco Giallombardo, Jorge Chacartegui, Nele Van Der Steen, Inge Mertens, Marc Peeters, Antonio Russo and Patrick Pauwels
Cancer Res August 1 2015 (75) (15 Supplement) 3382; DOI: 10.1158/1538-7445.AM2015-3382
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research (Excluding Clinical Trials)

  • Abstract LB-239: Pharmacodynamic changes confirm the mechanism of action mediating SD-101 efficacy, in combination with pembrolizumab, in a phase 1b/2 study in metastatic melanoma (MEL-01)
  • Abstract LB-238: Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC)
  • Abstract LB-252: Single-cell mRNA profiling reveal transcriptional heterogeneity among pancreatic circulating tumor cells
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Development of Prognostic and Predictive Biomarker Assays

  • Abstract 3390: Validating the RNAscope for molecular profiling of key biomarkers associated with gemcitabine resistance
  • Abstract 3400: Mitochondrial profiling in AML patients treated with an Alvocidib containing regimen reveals MCL1 dependency in responder bone marrow
  • Abstract 3389: A multiplexed immunohistochemistry test to screen for protein overexpression of ROS1, TrkA, TrkB and TrkC in multiple tumor tissue types
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement